CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 132, Issue 3, Pages 819-831
Publisher
Springer Nature
Online
2011-09-29
DOI
10.1007/s10549-011-1759-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer molecular profiles and tumor response of neoadjuvant doxorubicin and paclitaxel: The I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657)
- (2017) L. J. Esserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Autoreactive T Cells Escape Clonal Deletion in the Thymus by a CD24-Dependent Pathway
- (2014) J. W. Carl et al. JOURNAL OF IMMUNOLOGY
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Decoding Cell Death Signals in Inflammation and Immunity
- (2010) Laurence Zitvogel et al. CELL
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
- (2009) X.-R. Yang et al. CLINICAL CANCER RESEARCH
- CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection
- (2009) Dongling Li et al. HEPATOLOGY
- Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study
- (2009) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population
- (2009) Mohammad Ronaghi et al. PSYCHIATRY RESEARCH
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Antigen processing and CD24 expression determine antigen presentation by splenic CD4+and CD8+dendritic cells
- (2007) David Askew et al. IMMUNOLOGY
- ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
- (2007) Henrik Gréen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now